OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Cancer is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer	159
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial	137
CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles	131
Advancing radiomics from contrast-enhanced mammography in breast cancer	131
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients	130
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours	125
Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach	124
The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma	120
Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints	97
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?	94
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma	92
Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort	91
Correction to: EGFR/Ras-induced CCL20 production modulates the tumour microenvironment	91
A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case–control studies	90
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers	87
Years of life lost due to cancer in the United Kingdom from 1988 to 2017	86
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)	82
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis	81
Metastasis-associated fibroblasts in peritoneal surface malignancies	80
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer	78
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study	77
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours	77
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer	74
Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US	74
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening	74

Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis	73
Metabolic adaptations in prostate cancer	72
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities	71
Extruded small extracellular vesicles: splinters of circulating tumour cells may promote cancer metastasis?	71
Navigating therapeutic strategies: HPV classification in head and neck cancer	71
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer	71
DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma	71
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate	69
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity	66
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3	65
Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value	64
Genomic ALK alterations in primary and relapsed neuroblastoma	63
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)	63
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing	61
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer	61
The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis	58
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition	58
The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer	57
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours	57
Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis	56
Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England	56
Identification of increased dedifferentiation along the Prom1+ cancer cells in Müllerian adenosarcoma with sarcomatous overgrowth	56
Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma	53
Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme	53
Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner	53
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials	52
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination	52
Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors	52
Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas	52
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study	52
The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England	52